Status:
UNKNOWN
Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy
Lead Sponsor:
JFK Medical Center
Conditions:
Peripheral Neuropathy
Eligibility:
All Genders
18-75 years
Brief Summary
This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of Arginine) and mo...
Eligibility Criteria
Inclusion
- Men and Women Ages 18-75 with symptoms of small Fiber Neuropathy and have been diagnosed via autonomic function testing and or skin biopsy
Exclusion
- Women who are pregnant or breast feeding, patients with history of substance abuse, and patients with myelopathy
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01524666
Start Date
February 1 2012
End Date
October 1 2018
Last Update
February 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
JFK Medical Center
Edison, New Jersey, United States, 07712